Company Filing History:
1 out of 2,405 
1 out of 2 Years Active: 2023
Title: Kangze Dai: Innovator in Cancer Treatment
Introduction
Kangze Dai is a notable inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on the synthesis of important pharmaceutical compounds.
Latest Patents
Kangze Dai holds a patent for a synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. This patent provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor that is useful for treating cancer. The disclosure also outlines processes for isolating these crystalline forms, which can enhance the efficacy of the drug.
Career Highlights
Throughout his career, Kangze Dai has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH, where he has contributed to various research initiatives aimed at developing innovative treatments.
Collaborations
Kangze Dai has collaborated with esteemed colleagues in his field, including Stephen M. Dalby and Clinton Scott Shultz. These collaborations have further enriched his research and development efforts.
Conclusion
Kangze Dai's contributions to the field of cancer treatment through his innovative patent and collaborations with leading professionals highlight his importance as an inventor. His work continues to pave the way for advancements in pharmaceutical research.